Skip to main content

Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical Trial

In brief

On-site PCR testing reduces nursing home emergency transfers by up to 11%

In a cluster-randomized trial of 20 Toronto nursing homes, point-of-care multiplex PCR did not change the number or size of SARS-CoV-2, influenza, or RSV outbreaks, but it increased testing frequency and cut confirmed emergency department transfers by 3.5% and overall transfers by 11%. Death rates were unchanged, suggesting the main benefit is quicker case detection and antiviral treatment.

Journal
JAMA internal medicine (Q1)
Published
6 July 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Christopher Kandel, Daphne Oriotis, Heather L Candon, James Callahan, Christina K Chan, Aaron Truong, et al.
PMID
42406366
DOI
10.1001/jamainternmed.2026.2644

Why clinicians should know about it

  • Picked for Internal Medicine (top studies of the week, 22 November 2026): Point-of-care testing affects infection management and transfers

Abstract

IMPORTANCE: Respiratory infections caused by SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) cause pronounced seasonal morbidity and mortality among residents of nursing homes (NHs). OBJECTIVE: To assess the effect of an on-site point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) instrument on NH outbreaks. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, open-label cluster randomized trial was conducted from November 12, 2024, to May 2, 2025, in NHs in Toronto, Ontario, Canada. The data analysis was performed from October 7, 2025, until December 31, 2025. INTERVENTION: On-site POC-RMPCR by trained NH staff. MAIN OUTCOMES AND MEASURES: The primary outcome was jointly SARS-CoV-2, influenza, and RSV outbreak size and number, and secondary outcomes included the rates of resident emergency department (ED) transfer and death. RESULTS: Among 20 participating NHs with a total of 3963 beds, there was median of 5.5 units, with 30 beds per unit and a crowding index score of 1.42. The joint estimate of outbreak number (51 and 62, respectively) and size for the intervention group was no different from controls, with a rate ratio of 1.12 (95% CI, 0.78 to 1.58). ED transfers for confirmed (-3.5%; 95% CI, -7.2 to -0.2%) and confirmed/suspected infection (-11.0%; 95% CI, -20.6% to -2.0%) were lower among intervention NHs without a difference in death. Viral testing rates (3.69 tests/week vs 1.73 tests/week) and ratio of confirmed to suspect cases (4.2 vs 2.0) were higher in intervention homes along with a shorter time to initiation of antiviral therapy from symptom onset (-2.5 days; 95% CI, -3.1 to -1.9). CONCLUSIONS AND RELEVANCE: The results of this cluster randomized clinical trial suggests that use of a POC-RMPCR in NHs did not change outbreak number or size but decreased the number of ED transfers in the context of increased viral testing, improved case detection, and faster initiation of antiviral therapy for influenza. Seasonal adoption of POC-RMPCR in NHs would avoid an estimated 4 ED transfers per 100 beds. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06660433.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.